Use of Tofacitinib in the Context of COVID-19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases.

Mortezavi, Mahta; Menon, Sujatha; Lee, Kristen; Rivas, Jose

Mortezavi, Mahta; Menon, Sujatha; Lee, Kristen; Rivas, Jose.

Mortezavi M; Pfizer Inc, New York, NY.
Menon S; Pfizer Inc, New York, NY.
Lee K; Pfizer Inc, Groton, CT.
Rivas J; Pfizer SLU, Madrid, Spain.

Arthritis Rheumatol ; 73(9): 1768-1769, 2021 09.

Article in English | MEDLINE | ID: covidwho-1332947

Subject(s)

COVID-19; Rheumatic Diseases; Rheumatology; COVID-19 Vaccines; Humans; Piperidines; Pyrimidines; Rheumatic Diseases/drug therapy; SARS-CoV-2; United States; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatology / Rheumatic Diseases / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Arthritis Rheumatol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google